- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Getting Creative to Encourage Patient Engagement
Since the patient’s cost is effectively zero in the Medicaid population, getting patients engaged in their care often requires some ingenuity to figure out what the patient needs in order to be motivated in their own health, said Matt Salo.
“Is child care your biggest issue?” Salo asked. “Well let’s figure out: if you can go to the highest quality, lowest price provider, maybe we can kick in some child care subsidy or something like that. You can be creative.”
Figuring those things out is complicated, but can be done, and it aligns with the way insurance is changing to embrace social determinants of health, he added.
Leah Binder agreed that it is important to create incentives to creatively build benefits designs based on what the patients actually value. “But our healthcare system has no tradition at all of caring at all about what patients think,” she said.
And when the system does try to define quality, it’s usually in a scientific way that considers what is high quality or what the most people think. But the industry needs to start understanding the nuances between how different people view value, Binder said.
In the end, this will all come down to research, Austin Frakt, PhD, said. The data on these innovative models need to be available and accessible in order for independent researchers to know the effects of these programs.
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More
